NEPHROPLUS749.20

Nephrocare Health Services Limited

· Pharma & Health
AnnualQuarterly₹ CrorePeersKRSNAASURAKSHAHEALTHX3BBLACKBIOMcap ₹7,517 Cr
View
In ₹ Crore except Per Share
12 Months Ending
Q3 FY26
31/12/2025
Q4 FY26
31/03/2026
Q1 FY27
30/06/2026
Revenue from Operations259.7265.6281.8
Other Income3.311.67.5
Total Income263.0277.2289.2
Expenses
+ Cost of Materials Consumed58.559.662.4
+ Employee Benefit Expense43.145.947.8
+ Finance Costs6.03.22.2
+ Depreciation & Amortisation21.925.824.5
+ Other Expenses97.2106.3107.6
Total Expenses226.7240.9244.6
EBITDA60.953.863.9
EBIT39.027.939.3
Profit
PBT before Exceptional Items36.436.344.6
Pretax Income36.436.344.6
+ Current Tax9.48.812.1
+ Deferred Tax-5.3-5.9-3.0
Tax Expense4.12.89.1
+ Share of Associates & JVs0.0-3.1-3.6
Net Income32.230.432.0
+ Net Income — Continuing Ops32.233.535.5
+ Other Comprehensive Income1.65.91.1
Total Comprehensive Income33.836.333.1
Net Income to Common32.230.432.0
Per Share
Basic EPS3.433.033.19
Diluted EPS3.352.963.11
Other Comprehensive Income — detail
+ Other Comprehensive Income1.65.91.1
+ Items NOT to be Reclassified to P&L-0.10.10.0
+ Items to be Reclassified to P&L1.75.81.1
Comprehensive Income — Owners of Parent33.85.933.1
Per Share — as-filed variants
Basic EPS — Continuing Operations3.433.033.19
Diluted EPS — Continuing Operations3.352.963.11
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit201.2206.0219.3
Gross Margin %77.4777.5577.84
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)36.436.344.6
Net Income Adj (tax-effected)32.230.432.0
EPS Adj3.433.033.19
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value2.002.002.00
Paid Up Equity Capital20.120.120.1
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.